Dr. Hetty Carraway, an AML specialist at Cleveland Clinic, provides an explanation of the role of induction and consolidation therapy in AML patients. Dr. Hetty Carraway is Director of the Leukemia Program at Cleveland Clinic. [More]
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell Yarbrough discusses using induction to guide radiation. For more, please visit http://cancerGRACE.org/. To join the [More]
Completion pneumonectomy: right lower lobectomy after induction chemotherapy (previous bilobectomy) For more detail: http://www.asvide.com/articles/57
Jeffrey Lancet, MD, of H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses the relevance of high-dose chemotherapy in the treatment of acute myeloid leukemia (AML). This interview was recorded via an online [More]
In this segment, Dean F. Bajorin, MD, comments on treatment approaches for muscle-invasive bladder cancer.
Christoph Röllig, MD, MSc, Dresden University of Technology, Dresden, Germany, outlines the results of the randomized-controlled SAL-DaunoDouble trial (NCT02140242), comparing remission and survival in newly diagnosed acute myeloid leukemia (AML) patients treated after single versus [More]
Marshall R. Posner, MD, The Tisch Cancer Institute, New York, NY, describes an analysis of patients with locally advanced human papillomavirus (HPV)-positive oropharynx cancer (OPC) from two different trials (NCT02945631, NCT01706939) who received induction chemotherapy [More]
Carlo M. Contreras, MD, FACS, discusses the benefits of several neoadjuvant treatment options for patients with gastric cancer.
Earn CME for related activities: https://www.naccme.com/oln In this webcast from the ‘2019 ESMO World Congress on Gastrointestinal Cancer’, Dr. Thomas Seufferlein argues in favor of the use of neo-adjuvant chemotherapy for the treatment of resectable [More]